Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Randall, T. D.
Right arrow Articles by Weissman, I. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Randall, T. D.
Right arrow Articles by Weissman, I. L.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment

TD Randall and IL Weissman

Department of Pathology, Stanford Medical School, CA 94305, USA.

A significant fraction of hematopoietic stem cells (HSCs) have been shown to be resistant to the effects of cytotoxic agents such as 5- fluorouracil (5-FU), which is thought to eliminate many of the rapidly dividing, more committed progenitors in the bone marrow and to provide a relatively enriched population of the most primitive hematopoietic progenitor cells. Although differences between 5-FU-enriched progenitor populations and those from normal bone marrow have been described, it remained unclear if these differences reflected characteristics of the most primitive stem cells that were revealed by 5-FU, or if there were changes in the stem-cell population itself. Here, we have examined some of the properties of the stem cells in the bone marrow before and after 5-FU treatment and have defined several activation-related changes in the stem-cell population. We found that long-term reconstituting stem cells decrease their expression of the growth factor receptor c-kit by 10-fold and increase their expression of the integrin Mac-1 (CD11b). These changes begin as early as 24 hours after 5-FU treatment and are most pronounced within 2 to 3 days. This activated phenotype of HSCs isolated from 5-FU-treated mice is similar to the phenotype of stem cells found in the fetal liver and to the phenotype of transiently repopulating progenitors in normal bone marrow. We found that cell cycle is induced concomitantly with these physical changes, and within 2 days as many as 29% of the stem-cell population is in the S/G2/M phases of the cell cycle. Furthermore, when examined at a clonal level, we found that 5-FU did not appear to eliminate many of the transient, multipotent progenitors from the bone marrow that were found to be copurified with long-term repopulating, activated stem cells. These results demonstrate the sensitivity of the hematopoietic system to changes in its homeostasis and correlate the expression of several important surface molecules with the activation state of HSCs.

Volume 89, Issue 10, pp. 3596-3606, 05/15/1997
Copyright © 1997 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DevelopmentHome page
C. He, H. Hu, R. Braren, S.-Y. Fong, A. Trumpp, T. R. Carlson, and R. A. Wang
c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo
Development, July 15, 2008; 135(14): 2467 - 2477.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Daria, M.-D. Filippi, E. S. Knudsen, R. Faccio, Z. Li, T. Kalfa, and H. Geiger
The retinoblastoma tumor suppressor is a critical intrinsic regulator for hematopoietic stem and progenitor cells under stress
Blood, February 15, 2008; 111(4): 1894 - 1902.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. Pelayo, K. Miyazaki, J. Huang, K. P. Garrett, D. G. Osmond, and P. W. Kincade
Cell Cycle Quiescence of Early Lymphoid Progenitors in Adult Bone Marrow
Stem Cells, December 1, 2006; 24(12): 2703 - 2713.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Nemeth, M. R. Kirby, and D. M. Bodine
Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiation
PNAS, September 12, 2006; 103(37): 13783 - 13788.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
Y. Yamada and N. Takakura
Physiological pathway of differentiation of hematopoietic stem cell population into mural cells
J. Exp. Med., April 17, 2006; 203(4): 1055 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Suzuki, O. Ohneda, N. Minegishi, M. Nishikawa, T. Ohta, S. Takahashi, J. D. Engel, and M. Yamamoto
Combinatorial Gata2 and Sca1 expression defines hematopoietic stem cells in the bone marrow niche
PNAS, February 14, 2006; 103(7): 2202 - 2207.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. H. Yilmaz, M. J. Kiel, and S. J. Morrison
SLAM family markers are conserved among hematopoietic stem cells from old and reconstituted mice and markedly increase their purity
Blood, February 1, 2006; 107(3): 924 - 930.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. Surdez, B. Kunz, A. J. Wagers, I. L. Weissman, and A. V. Terskikh
Simple and Efficient Isolation of Hematopoietic Stem Cells from H2K-zFP Transgenic Mice
Stem Cells, October 1, 2005; 23(10): 1617 - 1625.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. N. Kotton, A. J. Fabian, and R. C. Mulligan
A novel stem-cell population in adult liver with potent hematopoietic-reconstitution activity
Blood, September 1, 2005; 106(5): 1574 - 1580.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Geiger, G. Rennebeck, and G. Van Zant
Regulation of hematopoietic stem cell aging in vivo by a distinct genetic element
PNAS, April 5, 2005; 102(14): 5102 - 5107.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Hidalgo, A. J. Peired, L. A. Weiss, Y. Katayama, and P. S. Frenette
The integrin {alpha}M{beta}2 anchors hematopoietic progenitors in the bone marrow during enforced mobilization
Blood, August 15, 2004; 104(4): 993 - 1001.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Uchida, B. Dykstra, K. Lyons, F. Leung, M. Kristiansen, and C. Eaves
ABC transporter activities of murine hematopoietic stem cells vary according to their developmental and activation status
Blood, June 15, 2004; 103(12): 4487 - 4495.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. M. Scott, G. V. Priestley, and T. Papayannopoulou
Deletion of {alpha}4 Integrins from Adult Hematopoietic Cells Reveals Roles in Homeostasis, Regeneration, and Homing
Mol. Cell. Biol., December 15, 2003; 23(24): 9349 - 9360.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Tripp, Y. Liu, M. Sieburg, J. Montalbano, S. Wrzesinski, and G. Feuer
Human T-Cell Leukemia Virus Type 1 Tax Oncoprotein Suppression of Multilineage Hematopoiesis of CD34+ Cells In Vitro
J. Virol., November 15, 2003; 77(22): 12152 - 12164.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X. Jiang, M. Stuible, Y. Chalandon, A. Li, W. Y. Chan, W. Eisterer, G. Krystal, A. Eaves, and C. Eaves
Evidence for a positive role of SHIP in the BCR-ABL-mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia
Blood, October 15, 2003; 102(8): 2976 - 2984.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Stier, T. Cheng, R. Forkert, C. Lutz, D. M. Dombkowski, J. L. Zhang, and D. T. Scadden
Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells
Blood, August 15, 2003; 102(4): 1260 - 1266.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. M. Bjornsson, N. Larsson, A. C. M. Brun, M. Magnusson, E. Andersson, P. Lundstrom, J. Larsson, E. Repetowska, M. Ehinger, R. K. Humphries, et al.
Reduced Proliferative Capacity of Hematopoietic Stem Cells Deficient in Hoxb3 and Hoxb4
Mol. Cell. Biol., June 1, 2003; 23(11): 3872 - 3883.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. S. Radomska, D. A. Gonzalez, Y. Okuno, H. Iwasaki, A. Nagy, K. Akashi, D. G. Tenen, and C. S. Huettner
Transgenic targeting with regulatory elements of the human CD34 gene
Blood, December 15, 2002; 100(13): 4410 - 4419.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. L. Bradley, T. S. Hawley, and K. D. Bunting
Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells
Blood, December 1, 2002; 100(12): 3983 - 3989.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X. Jiang, E. Ng, C. Yip, W. Eisterer, Y. Chalandon, M. Stuible, A. Eaves, and C. J. Eaves
Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo
Blood, November 15, 2002; 100(10): 3731 - 3740.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Zhang, E. Nelson, H. S. Radomska, J. Iwasaki-Arai, K. Akashi, A. D. Friedman, and D. G. Tenen
Induction of granulocytic differentiation by 2 pathways
Blood, May 29, 2002; 99(12): 4406 - 4412.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Graf
Differentiation plasticity of hematopoietic cells
Blood, May 1, 2002; 99(9): 3089 - 3101.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Okuno, H. Iwasaki, C. S. Huettner, H. S. Radomska, D. A. Gonzalez, D. G. Tenen, and K. Akashi
Differential regulation of the human and murine CD34 genes in hematopoietic stem cells
PNAS, April 30, 2002; 99(9): 6246 - 6251.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. He, J. A. Wertheim, L. Xu, J. P. Miller, F. G. Karnell, J. K. Choi, R. Ren, and W. S. Pear
The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl
Blood, April 15, 2002; 99(8): 2957 - 2968.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Levin, L. Cocault, C. Demerens, C. Challier, M. Pauchard, J. Caen, and M. Souyri
Thrombocytopenic c-mpl{-}/{-} mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response
Blood, August 15, 2001; 98(4): 1019 - 1027.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Y. Li, J. Chen, L. Wang, M. Lu, and M. Chopp
Treatment of stroke in rat with intracarotid administration of marrow stromal cells
Neurology, June 26, 2001; 56(12): 1666 - 1672.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Tajima, T. Deguchi, J. H. Laver, H. Zeng, and M. Ogawa
Reciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells
Blood, May 1, 2001; 97(9): 2618 - 2624.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. Domen and I. L. Weissman
Hematopoietic Stem Cells Need Two Signals to Prevent Apoptosis; BCL-2 Can Provide One of These, Kitl/c-Kit Signaling the Other
J. Exp. Med., December 11, 2000; 192(12): 1707 - 1718.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Tajima, T. Sato, J. H. Laver, and M. Ogawa
CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor
Blood, September 1, 2000; 96(5): 1989 - 1993.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
F. G. Murante and T. A. Gasiewicz
Hemopoietic Progenitor Cells Are Sensitive Targets of 2,3,7,8-Tetrachlorodibenzo-p-dioxin in C57BL/6J Mice
Toxicol. Sci., April 1, 2000; 54(2): 374 - 383.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. Domen, S. H. Cheshier, and I. L. Weissman
The Role of Apoptosis in the Regulation of Hematopoietic Stem Cells: Overexpression of BCL-2 Increases Both Their Number and Repopulation Potential
J. Exp. Med., January 17, 2000; 191(2): 253 - 264.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Sato, J. H. Laver, and M. Ogawa
Reversible Expression of CD34 by Murine Hematopoietic Stem Cells
Blood, October 15, 1999; 94(8): 2548 - 2554.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. H. Cheshier, S. J. Morrison, X. Liao, and I. L. Weissman
In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells
PNAS, March 16, 1999; 96(6): 3120 - 3125.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Reid, A. Ritchie, L. Boring, J. Gosling, S. Cooper, G. Hangoc, I. F. Charo, and H. E. Broxmeyer
Enhanced Myeloid Progenitor Cell Cycling and Apoptosis in Mice Lacking the Chemokine Receptor, CCR2
Blood, March 1, 1999; 93(5): 1524 - 1533.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Uchida, R. E. Sutton, A. M. Friera, D. He, M. J. Reitsma, W. C. Chang, G. Veres, R. Scollay, and I. L. Weissman
HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells
PNAS, September 29, 1998; 95(20): 11939 - 11944.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Veena, C. M. Traycoff, D. A. Williams, J. McMahel, S. Rice, K. Cornetta, and E. F. Srour
Delayed Targeting of Cytokine-Nonresponsive Human Bone Marrow CD34+ Cells With Retrovirus-Mediated Gene Transfer Enhances Transduction Efficiency and Long-Term Expression of Transduced Genes
Blood, May 15, 1998; 91(10): 3693 - 3701.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Wlodarski, M. Wasik, M. Z. Ratajczak, C. Sevignani, G. Hoser, J. Kawiak, A. M. Gewirtz, B. Calabretta, and T. Skorski
Role of p53 in Hematopoietic Recovery After Cytotoxic Treatment
Blood, April 15, 1998; 91(8): 2998 - 3006.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. J. M. Zijlmans, J. W. M. Visser, L. Laterveer, K. Kleiverda, D. P. M. Heemskerk, P. M. Kluin, R. Willemze, and W. E. Fibbe
The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells
PNAS, January 20, 1998; 95(2): 725 - 729.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
T. D. Randall and I. L. Weissman
Characterization of a Population of Cells in the Bone Marrow that Phenotypically Mimics Hematopoietic Stem Cells: Resting Stem Cells or Mystery Population?
Stem Cells, January 1, 1998; 16(1): 38 - 48.
[Abstract] [Full Text]


Home page
BloodHome page
N. Uchida, A. M. Friera, D. He, M. J. Reitsma, A. S. Tsukamoto, and I. L. Weissman
Hydroxyurea Can Be Used to Increase Mouse c-kit+Thy-1.1loLin-/loSca-1+ Hematopoietic Cell Number and Frequency in Cell Cycle In Vivo
Blood, December 1, 1997; 90(11): 4354 - 4362.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. A. Allay, H. T. Spencer, S. L. Wilkinson, J. A. Belt, R. L. Blakley, and B. P. Sorrentino
Sensitization of Hematopoietic Stem and Progenitor Cells to Trimetrexate Using Nucleoside Transport Inhibitors
Blood, November 1, 1997; 90(9): 3546 - 3554.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us